Online citations, reference lists, and bibliographies.
← Back to Search

Brain Uptake Of Thiamine-coated Nanoparticles.

P. Lockman, M. Oyewumi, J. Koziara, K. Roder, R. Mumper, D. Allen
Published 2003 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Recently, a novel nanoparticle (NP) comprised of emulsifying wax and Brij 78 was shown to have significant brain uptake using the in-situ rat brain perfusion technique. To further these studies and to specifically target brain, we have incorporated thiamine as a surface ligand on the nanoparticles. Solid nanoparticles were prepared from oil-in-water microemulsion precursors. Nanoparticles were radiolabeled and a thiamine ligand (thiamine linked to distearoylphosphatidylethanolamine via a polyethylene glycol spacer) was coated on the surface of the nanoparticles. Initial experiments focused on assessing uptake of [3H]nanoparticles with and without thiamine surface ligands. Biodistribution nanoparticle studies were also carried out in BALB/c mice. The results showed: (1) the effectiveness of using microemulsions as precursors to engineer nanoparticles, (2) kinetic modeling for brain uptake of nanoparticles with and without the thiamine surface ligands, and (3) initial data suggesting mechanisms for nanoparticle brain entry. Comparison of NP brain uptake demonstrated that the thiamine-coated nanoparticle associated with the blood-brain barrier (BBB) thiamine transporter and had an increased K(in) between 45 and 120 s (thiamine coated NP 9.8 +/- 1.1 x 10(-3) ml/s/g versus uncoated NPs; 7.0 +/- 0.3 x 10(-3) ml/s/g). It was concluded that the thiamine ligand facilitated binding and/or association with blood-brain barrier thiamine transporters, which may be a viable mechanism for nanoparticle mediated brain drug delivery.
This paper references
Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells.
S. Wang (1998)
Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system.
Q. R. Smith (1996)
Physiological Parameters in Laboratory Animals and Humans
Brian R. Davies (2004)
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
A. Gulyaev (2004)
Kinetics of thiamine transport across the blood‐brain barrier in the rat.
J. Greenwood (1982)
Gadolinium-Loaded Nanoparticles Engineered from Microemulsion Templates
M. Oyewumi (2002)
In Vivo and in Vitro Assessment of Baseline Blood-Brain Barrier Parameters in the Presence of Novel Nanoparticles
P. Lockman (2004)
Drug and Gene Delivery to the Brain The Vascular Route
W. Pardridge (2002)
Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
R. Alyautdin (1998)
Evaluation of blood–brain barrier thiamine efflux using the in situ rat brain perfusion method
P. Lockman (2003)
Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections
U. Schroeder (1996)
Frontiers in Cerebral Vascular Biology: Transport and Its Regulation. Proceedings of CVB '92. Duluth, Minnesota, July 11-13, 1992.
L. Drewes (1993)
Introduction to the Blood–Brain Barrier: Development of Brain Efflux Index (BEI) method and its application to the blood–brain barrier efflux transport study
T. Terasaki (1998)
Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting.
S. Vyas (2001)
The Blood-brain Barrier and Drug Delivery to the CNS
D. Begley (2000)
Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting
I. Brigger (2002)
Drug delivery to brain and the role of carrier-mediated transport.
Quentin R. Smith (1993)
Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters.
M. Oyewumi (2003)
Brain drug targeting and gene technologies.
W. Pardridge (2001)
Morphology of blood-brain interfaces.
M. Brightman (1977)
Using Nanoparticles to Target Drugs to the Central Nervous System
R. Alyautdin (2000)
An in situ brain perfusion technique to study cerebrovascular transport in the rat.
Y. Takasato (1984)
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
P. Lockman (2002)
Characterization of the blood–brain barrier choline transporter using the in situ rat brain perfusion technique
D. D. Allen (2001)
In Situ Blood–Brain Barrier Transport of Nanoparticles
J. Koziara (2004)

This paper is referenced by
The effect of ZnO Nps of 20 nm on changes of enzyme and liver tissues of pregnant NMRI mice
bager Seyed Alipour (2015)
Immunociblage du cerveau par des nanocapsules lipidiques
A. Béduneau (2007)
Nose-to-Brain Drug Delivery Enabled by Nanocarriers
Zachary N. Warnken (2021)
The Effect of Ventilation, Age, and Asthmatic Condition on Ultrafine Particle Deposition in Children
H. Olvera (2012)
Biomolecule–Nanoparticle Hybrid Systems
M. Zayats (2010)
Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles.
R. Mejías (2010)
Ligand-mediated transport of drug delivery devices across the blood-brain barrier
Julia V. Georgieva (2012)
Assessment of the relative performance of a confined impinging jets mixer and a multi-inlet vortex mixer for curcumin nanoparticle production.
S. F. Chow (2014)
Nanomaterials for Drug Delivery to the Central Nervous System
D. Teleanu (2019)
Nanosized Minicells Generated by Lactic Acid Bacteria for Drug Delivery
Huu Ngoc Nguyen (2017)
Solid lipid nanoparticles for drug delivery
M. Harms (2011)
Nanometric agents in the service of neuroscience: Manipulation of neuronal growth and activity using nanoparticles.
Pazit Polak (2015)
Nanoparticulate targeted drug delivery using peptides and proteins
H. Santos (2012)
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
E. Souto (2010)
Immuno-nanosystems to CNS pathologies: state of art
G. Tosi (2012)
Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art.
L. Gastaldi (2014)
Investigating potential toxicity of phenanthrene adsorbed to nano-ZnO using Daphnia magna
K. Naddafi (2011)
Targeted immunomodulation using antigen-conjugated nanoparticles.
D. McCarthy (2014)
Serum biochemical status and morphological changes in mice ovary associated with copper oxide nanoparticles after thiamine therapy
R. Fatahian-Dehkordi (2016)
Nanoparticulate Drug Delivery Systems
Jaya Raja Kumar Kalaimani (2016)
Solid lipid nanoparticles
M. Shah (2017)
Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain
S. Salunkhe (2016)
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho (2008)
Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis
Ghasem Ghalamfarsa (2016)
Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
M. Muthu (2009)
Targeted Drug Delivery for Personalized Cure
R. Chaudhari (2017)
Dendrimer-mediated approaches for the treatment of brain tumor
N. Dwivedi (2016)
Brain Delivery by Nanoparticles
S. Gelperina (2006)
SyM-BBB: a microfluidic Blood Brain Barrier model.
B. Prabhakarpandian (2013)
Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles
Mei Xue (2013)
Lipids as Biological Materials for Nanoparticulate Delivery
I. P. Kaur (2014)
Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS.
M. Gagliardi (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar